TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28371482

Group type: EXPERIMENTAL
Intervention: 1% brinzolamide/0.5% timolol fixed combination (BTFC)
Number of subjects: 201

Group type: COMPARATOR
Intervention: 1% dorzolamide/0.5% timolol fixed combination (DTFC)
Number of subjects: 201
Study: 25265147

Group type: EXPERIMENTAL
Intervention: Remifentanil (1 μg/kg) and thiopental sodium (4 mg/kg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Thiopental sodium (3 mg/kg, placebo)
Number of subjects: 120
Study: 22234379

Group type: EXPERIMENTAL
Intervention: D-cycloserine (DCS) only
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: D-cycloserine (DCS) before sessions 1 and 3, placebo (PBO) before session 2
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (PBO) only
Number of subjects: 32
Study: 21693655

Group type: EXPERIMENTAL
Intervention: Doxorubicin (60, 75, or 90 mg/m²) and cyclophosphamide with paclitaxel
Number of subjects: 3121

Group type: COMPARATOR
Intervention: Doxorubicin (60, 75, or 90 mg/m²) and cyclophosphamide without paclitaxel
Number of subjects: 3121
Study: 18269666

Group type: EXPERIMENTAL
Intervention: Test group treated with the proposed surgical technique without releasing incisions
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group treated with a broader flap and vertical-releasing incisions
Number of subjects: 15
Study: 17138264

Group type: EXPERIMENTAL
Intervention: Individualized cognitive/sensorimotor stimulation program for infants, taught by public health nurses (PHNs) using the Curriculum and Monitoring System (CAMS).
Number of subjects: 62

Group type: COMPARATOR
Intervention: State‐funded follow‐up program provided by the Los Angeles (LA) Regional Centers.
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Individualized cognitive/sensorimotor stimulation program for infants.
Number of subjects: 62
Study: 12650957

Group type: EXPERIMENTAL
Intervention: mianserin (15 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study: 11019421

Group type: EXPERIMENTAL
Intervention: L-arginine (15 g/day for 10 days)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 42
Study: 8629674

Group type: EXPERIMENTAL
Intervention: Melphalan, prednisone, and colchicine (MPC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Colchicine (C)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: MPC
Number of subjects: 100
Study: 1420212

Group type: EXPERIMENTAL
Intervention: 1‐hr school‐based AIDS/HIV education program (n = 535)
Number of subjects: 1194

Group type: COMPARATOR
Intervention: Control group (n = 659)
Number of subjects: 1194
Study: 3880810

Group type: EXPERIMENTAL
Intervention: MVP (mitomycin C, vinblastine, and cisplatin)
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: CBP (cyclophosphamide, bleomycin, and cisplatin)
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: AFP (doxorubicin, 5-fluorouracil, and cisplatin)
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: CAP (cyclophosphamide, doxorubicin, and cisplatin)
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Overall response rates for all regimens
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Survival by treatment
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Complications of therapy
Number of subjects: 479
Study: 31535359

Group type: EXPERIMENTAL
Intervention: Platelet rich plasma
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 30
Study: 29925515

Group type: EXPERIMENTAL
Intervention: Precision Nutrition lifestyle program (12 months)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study: 27150644

Group type: EXPERIMENTAL
Intervention: Partial opening of the inner hematoma membrane (group A)
Number of subjects: 52

Group type: COMPARATOR
Intervention: No opening of the inner hematoma membrane (group B)
Number of subjects: 52
Study: 23241505

Group type: EXPERIMENTAL
Intervention: IL-2 plus LMI vaccine
Number of subjects: 21

Group type: COMPARATOR
Intervention: IL-2 alone
Number of subjects: 21
Study: 22104057

Group type: COMPARATOR
Intervention: e-mail arm
Number of subjects: 51

Group type: COMPARATOR
Intervention: lecture arm
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: coaching arm
Number of subjects: 51
Study: 18603261

Group type: EXPERIMENTAL
Intervention: Moderate treadmill exercise (70% of HR(max))
Number of subjects: 92

Group type: COMPARATOR
Intervention: Quiet rest
Number of subjects: 92
Study: 17471790

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch (14 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Voucher-based reinforcement
Number of subjects: 14

Group type: COMPARATOR
Intervention: Comparison of both treatments
Number of subjects: 14
Study: 15212838

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI) assessment of transverse relaxation rates (R2) in the genu (Gcc) and splenium (Scc) of the corpus callosum.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-invasive measures such as R2.
Number of subjects: 0
Study: 12377083

Group type: EXPERIMENTAL
Intervention: Early invasive strategy with routine catheterization and revascularization as appropriate
Number of subjects: 2220

Group type: COMPARATOR
Intervention: Conservative strategy with catheterization performed only for recurrent ischemia or a positive stress test
Number of subjects: 2220

Group type: EXPERIMENTAL
Intervention: Early invasive strategy
Number of subjects: 2220

Group type: COMPARATOR
Intervention: Conservative strategy
Number of subjects: 2220
Study: 9614518

Group type: EXPERIMENTAL
Intervention: High-resolution ultrasound (Biovision B-Scan Probe)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Heidelberg Retinal Tomograph (HRT)
Number of subjects: 20
Study: 9071621

Group type: EXPERIMENTAL
Intervention: Terbinafine 125 mg orally twice daily for 4 weeks (Group 1, ages 5-15)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Terbinafine 250 mg orally twice daily for 4 weeks (Group 2, ages > 15)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sodium stibogluconate intralesionally (for patients with partial cure or failure)
Number of subjects: 27
Study: 2023034

Group type: EXPERIMENTAL
Intervention: Collagraft
Number of subjects: 267

Group type: COMPARATOR
Intervention: Cancellous iliac crest autograft
Number of subjects: 267
Study: 7361797

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (1 g four times daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31645648

Group type: EXPERIMENTAL
Intervention: Low-pLSC6 group (n=97)
Number of subjects: 163

Group type: COMPARATOR
Intervention: High-pLSC6 group (n=66)
Number of subjects: 163
Study: 30550828

Group type: EXPERIMENTAL
Intervention: Tezepelumab 280 mg plus class 3 topical corticosteroids (TCS)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo plus class 3 topical corticosteroids (TCS)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Tezepelumab plus TCS
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo plus TCS
Number of subjects: 113
Study: 27576298

Group type: EXPERIMENTAL
Intervention: Multimodal standard nursing program (MSNP) plus routine nursing care
Number of subjects: 12

Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 12
Study: 23336594

Group type: EXPERIMENTAL
Intervention: MYO 2 g plus folic acid 200 mg every day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Folic acid 200 mg every day
Number of subjects: 50
Study: 21070547

Group type: EXPERIMENTAL
Intervention: Open-angle glaucoma patients
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study: 20012809

Group type: EXPERIMENTAL
Intervention: Combined intervention (tailored print communication and brief telephone-based motivational interviewing)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tailored print communication (TPC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: None of the interventions
Number of subjects: 0
Study: 17347063

Group type: EXPERIMENTAL
Intervention: ZOL 5 mg
Number of subjects: 128

Group type: COMPARATOR
Intervention: ALN 70 mg
Number of subjects: 128
Study: 14748812

Group type: EXPERIMENTAL
Intervention: Lorazepam (n = 28)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Midazolam (n = 21)
Number of subjects: 49
Study: 11785453

Group type: EXPERIMENTAL
Intervention: Microfilaraemia detection using thick drop technique and nucleopore filtration technique.
Number of subjects: 4646

Group type: EXPERIMENTAL
Intervention: Clinical examinations for disease manifestations.
Number of subjects: 4646

Group type: EXPERIMENTAL
Intervention: Observation of occult filarial manifestations.
Number of subjects: 4646
Study: 9301399

Group type: EXPERIMENTAL
Intervention: Extradural buprenorphine
Number of subjects: 2

Group type: COMPARATOR
Intervention: Continuous extradural bupivacaine
Number of subjects: 2
Study: 8373713

Group type: EXPERIMENTAL
Intervention: Zolpidem 5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zolpidem 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nitrazepam 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zolpidem (5 and 10 mg) after seven nightly doses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nightly administration of zolpidem
Number of subjects: 0
Study: 3763945

Group type: EXPERIMENTAL
Intervention: Meteneprost potassium (a PGE2 analogue)
Number of subjects: 30
Study: 29865169

Group type: EXPERIMENTAL
Intervention: Whole nut consumption
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nut butter consumption
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Walnuts with yogurt
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 50
Study: 28027368

Group type: EXPERIMENTAL
Intervention: Friendship Bench intervention (6 sessions of individual problem-solving therapy delivered by trained, supervised lay health workers plus an optional 6-session peer support program)
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Friendship Bench intervention
Number of subjects: 573

Group type: COMPARATOR
Intervention: Enhanced usual care (control)
Number of subjects: 573
Study: 24534735

Group type: EXPERIMENTAL
Intervention: £1000 incentive
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: £25 incentive
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: £1000 incentive without cognitive load
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: £25 incentive without cognitive load
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: £1000 incentive under cognitive load
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: £25 incentive under cognitive load
Number of subjects: 275
Study: 23134686

Group type: EXPERIMENTAL
Intervention: Proactive telemarketing approach to promote healthy eating, physical activity, and weight loss
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proactive support services offered via telemarketing
Number of subjects: 0
Study: 19631948

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20mg
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Venlafaxine 150mg
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20mg and Venlafaxine 150mg
Number of subjects: 94
Study: 18586659

Group type: EXPERIMENTAL
Intervention: Telavancin 7.5 mg/kg
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Telavancin 15 mg/kg
Number of subjects: 79
Study: 16028436

Group type: EXPERIMENTAL
Intervention: 12-week physical activity programme (30 min of brisk walking and a daily 11-min home-based programme)
Number of subjects: 43
Study: 12503699

Group type: EXPERIMENTAL
Intervention: Terbutaline inhaled 10 min before mannitol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Terbutaline inhaled 5 min after mannitol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Terbutaline inhaled 10 min before the control for mannitol
Number of subjects: 20
Study: 10519734

Group type: EXPERIMENTAL
Intervention: Simvastatin (mean dose 28.6 mg/day)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Cholestyramine (mean dose 19.3 g/day)
Number of subjects: 43
Study: 7734901

Group type: EXPERIMENTAL
Intervention: Caffeine citrate 20 mg/kg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Aminophylline 5 mg/kg
Number of subjects: 33
Study: 2007101

Group type: EXPERIMENTAL
Intervention: Intercostal nerve block with 2% lidocaine plus epinephrine (Group A)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Intercostal nerve block with 2% lidocaine plus ornipressin (Group B)
Number of subjects: 45

Group type: COMPARATOR
Intervention: General anesthesia (Control group)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Regional anesthesia (ICNB)
Number of subjects: 45
Study: 7187082

Group type: EXPERIMENTAL
Intervention: Use of the logistic function probabilities provided to emergency room physicians (401 patients with probabilities)
Number of subjects: 643

Group type: COMPARATOR
Intervention: Standard diagnostic modalities without logistic function probabilities (455 patients without probabilities)
Number of subjects: 643
Study: 31577671

Group type: EXPERIMENTAL
Intervention: Sirolimus (SIR) with 50% reduction of CNI
Number of subjects: 525

Group type: COMPARATOR
Intervention: Standard CNI-based immunosuppression
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Sirolimus (SIR) with early CNI minimization
Number of subjects: 525
Study: 31286118

Group type: EXPERIMENTAL
Intervention: Glycine air polishing (G)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate air polishing (B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Manual scaling with carbon-fiber curette (C)
Number of subjects: 30
Study: 28500784

Group type: EXPERIMENTAL
Intervention: DL‐PDT (Daylight Photodynamic Therapy)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Fractional laser‐assisted DL‐PDT
Number of subjects: 28
Study: 27466241

Group type: EXPERIMENTAL
Intervention: Booklet providing information to fathers during their partners' pregnancies
Number of subjects: 554

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 554
Study: 25123092

Group type: EXPERIMENTAL
Intervention: PACU
Number of subjects: 200

Group type: COMPARATOR
Intervention: ICU
Number of subjects: 200
Study: 21075536

Group type: EXPERIMENTAL
Intervention: Octenidine-Gel®
Number of subjects: 30

Group type: COMPARATOR
Intervention: Flammazine®
Number of subjects: 30
Study: 19776406

Group type: EXPERIMENTAL
Intervention: High-dose daunorubicin (90 mg/m²) plus cytarabine (100 mg/m²)
Number of subjects: 657

Group type: COMPARATOR
Intervention: Standard-dose daunorubicin (45 mg/m²) plus cytarabine (100 mg/m²)
Number of subjects: 657
Study: 17598694

Group type: EXPERIMENTAL
Intervention: Reference formulation of topiramate (25 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Test formulation of topiramate (25 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Truncated AUCs
Number of subjects: 24
Study: 15380493

Group type: EXPERIMENTAL
Intervention: Mailing practice guidelines to primary care physicians after patient discharge
Number of subjects: 832
Study: 11303823

Group type: EXPERIMENTAL
Intervention: Once daily (OD) gentamicin dosing
Number of subjects: 179

Group type: COMPARATOR
Intervention: Three times daily (TD) gentamicin dosing
Number of subjects: 179
Study: 9600579

Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg oral m-CPP
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg oral m-CPP
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg oral m-CPP (females only)
Number of subjects: 12
Study: 7992274

Group type: EXPERIMENTAL
Intervention: Active treatment with Elmedistraal
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 12
Study: 3290005

Group type: EXPERIMENTAL
Intervention: Cyclosporin A
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 30292454

Group type: EXPERIMENTAL
Intervention: Self-training group assisted by an integrated video recording system during training (Group B)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Natural self-training group without a trainer (Group A)
Number of subjects: 50
Study: 28301205

Group type: EXPERIMENTAL
Intervention: Leukocyte-Poor Platelet-Rich Plasma (Lp-PRP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Leukocyte-Rich Platelet-Rich Plasma (Lr-PRP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 24
Study: 25573406

Group type: EXPERIMENTAL
Intervention: Tiotropium+olodaterol FDC 2.5/5 μg
Number of subjects: 5162

Group type: EXPERIMENTAL
Intervention: Tiotropium+olodaterol FDC 5/5 μg
Number of subjects: 5162

Group type: COMPARATOR
Intervention: Tiotropium 2.5 μg
Number of subjects: 5162

Group type: COMPARATOR
Intervention: Tiotropium 5 μg
Number of subjects: 5162

Group type: COMPARATOR
Intervention: Olodaterol 5 μg
Number of subjects: 5162
Study: 23618609

Group type: EXPERIMENTAL
Intervention: Epidural analgesia (EP group) with bupivacaine
Number of subjects: 132

Group type: COMPARATOR
Intervention: Subcutaneous morphine (SC group) with fentanyl
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Epidural analgesia (EP group)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Subcutaneous morphine (SC group)
Number of subjects: 132
Study: 21471821

Group type: EXPERIMENTAL
Intervention: Beetroot juice (BR; containing ∼ 6.2 mmol of nitrate)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (placebo, PL; containing ∼ 0.0047 mmol of nitrate)
Number of subjects: 9
Study: 18299546

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention (telephone-based education for patients and guidelines for physicians)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Number of subjects: 272
Study: 17219967

Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of Triptorelin (3.75 mg) at 6-week intervals
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Intramuscular administration of Triptorelin (3.75 mg) at 4-week intervals
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both treatment regimes (SC and IM)
Number of subjects: 46
Study: 12953165

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day
Number of subjects: 55
Study: 10793603

Group type: EXPERIMENTAL
Intervention: Quinaprilat 0.02 mg kg‐1 (group A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Quinaprilat 0.04 mg kg‐1 (group B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline solution (group C)
Number of subjects: 30
Study: 8805989

Group type: EXPERIMENTAL
Intervention: Active PEMF coils
Number of subjects: 13

Group type: COMPARATOR
Intervention: Inactive PEMF coils
Number of subjects: 13
Study: 1282428

Group type: EXPERIMENTAL
Intervention: Dual marker analysis flow‐cytometry using CD5 and CD19 markers
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: PCR analysis of the configuration of the Ig heavy chain gene region
Number of subjects: 23
Study: 6691878

Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 61

Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 61
Study: 31680610

Group type: EXPERIMENTAL
Intervention: Ambulatory Surgery Center (ASC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Arthroplasty Ward
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: ASC for TKA
Number of subjects: 50

Group type: COMPARATOR
Intervention: Arthroplasty Ward for TKA
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: ASC for THA
Number of subjects: 50
Study: 30642076

Group type: EXPERIMENTAL
Intervention: TNF-α inhibitors (TNFi)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 30373740

Group type: EXPERIMENTAL
Intervention: Curcumin (2000-mg doses 8 times over 4 days)
Number of subjects: 606

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 606

Group type: EXPERIMENTAL
Intervention: Curcumin
Number of subjects: 606
Study: 27829388

Group type: EXPERIMENTAL
Intervention: Maternal Oral Screening (MOS) tool
Number of subjects: 211

Group type: COMPARATOR
Intervention: Oral Health Impact Profile (OHIP-14)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Dental assessment by trained study dentists
Number of subjects: 211
Study: 24797294

Group type: EXPERIMENTAL
Intervention: Antimicrobial treatment (40 mg/kg of amoxicillin‐clavulanate per day for 7 days)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Antimicrobial treatment
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 22039291

Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OC) containing 0.5 mg NE and 0.035 mg EE
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: OC plus telaprevir (750 mg every 8 hours)
Number of subjects: 24
Study: 20561115

Group type: EXPERIMENTAL
Intervention: Individually tailored oral health educational programme (ITOHEP)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Standard oral hygiene education (ST)
Number of subjects: 113
Study: 17173280

Group type: EXPERIMENTAL
Intervention: Coping Skills Training (CST)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 40
Study: 15887056

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Balanced amino acid drink (control)
Number of subjects: 9
Study: 12040477

Group type: EXPERIMENTAL
Intervention: 400 microg rhGM-CSF solution (group A, n = 18)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Saline solution (group B, n = 23)
Number of subjects: 41
Study: 9822000

Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isoflurane anesthesia
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both anesthetics
Number of subjects: 60
Study: 7853451

Group type: EXPERIMENTAL
Intervention: Submaximal aerobic exercise (12 min at 63% VO2 max)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (completed two short unrelated questionnaires for 12 min)
Number of subjects: 60
Study: 2548554

Group type: EXPERIMENTAL
Intervention: Cilazapril 0.5 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cilazapril 1 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cilazapril 0.5 mg daily (multiple dose phase)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cilazapril 1 mg daily (multiple dose phase)
Number of subjects: 10
Study: 73949

Group type: EXPERIMENTAL
Intervention: Surgical treatment (coronary bypass surgery)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 0